Reimbursement policy has been a driver of change in the way hospitals handle heart failure patients.
When CMS started penalizing hospitals that readmitted too many patients within 30 days of discharge, heart failure patients were those most in need of attention. These patients tend to be older with other health issues, and under the traditional fee-for-service payment systems, there was little incentive to find ways to keep them from coming back after discharge.
By 2015, 30-day readmission was a $17 billion problem for Medicare and Medicaid and heart failure was the most common cause. It’s a problem tied to socioeconomic factors, but that’s not the whole story: current estimates find about 20% of heart failure patients are readmitted within 30 days and 50% within 6 months.
But hospitals can turn things around quickly with the right approach. At the 2017 American Heart Association (AHA) Scientific Sessions, Amar Bhakta, MD, of Rush University Medical Center in Chicago, Illinois, presented results from his hospital’s clinical pathway for heart failure. Preventing readmissions starts the moment the patient enters the emergency department, and involves a multidisciplinary team, help from outside the hospital, and most of all, a plan to ensure follow-up with the patient’s primary care physician.
A chart review for 2016 shows the results: From January 1, 2016, to June 30, 2016, before the pathway took effect, the 30-day readmission rate for heart failure patients was 22.5% (88 of 393 patients). From July 1, 2016, through December 31, 2016, the rate was 16.6% (66 of 367 patients).
Rush’s pathway involves professionals from across the health system: social workers nurses, nurse practitioners, pharmacists, physicians, hospitalists, heart failure physicians, and administrators. The pathway features standardized admission orders, specific medications, heart failure consult criteria, and criteria for admission to the cardiac intensive care unit, which were included in the abstract presented at AHA. The detailed chart spells out when additional consults with the heart failure specialists occur, what happens if patients gain or lose weight, and what to do given certain renal outcomes.
The critical element of the pathway is the follow-up process: patients leave the hospital with plans to see a nurse practitioner within 7 days of discharge and their PCP within 3 weeks. In an interview with The American Journal of Managed Care®, Bhakta said for the population that Rush serves, this second part isn’t always easy. But the focus shows in the results: the mean time to follow-up fell from 13 days, (±1.51 days) in the first 6 months of 2016 to just 8 days (±0.92 days) in the second 6 months.
Changing reimbursement models are driving much of the change, Bhakta said.
“It’s getting most hospitals into a different way of thinking, not just from a reimbursement perspective, but also from a patient-centered perspective,” he said. “Patients don’t want to be readmitted if they’re experiencing symptoms. If hospitals aren’t being reimbursed, whatever can be done in an appropriate way should be done.”
Reference
Moseley A, Accavitti MJ, Bhakta A, et al. Reducing heart failure readmissions using a multidisciplinary approach. Presented at the 2017 American Heart Association Scientific Sessions, Anaheim, California; November 11-15, 2017. M4062.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More